WallStreetZenWallStreetZen

NASDAQ: MCRB
Seres Therapeutics Inc Stock Ownership - Who owns Seres Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Seres Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eric D. ShaffCEO and President2025-05-16220$7.28
$1.60kSell
Matthew R. HennChief Scientific Officer and EVP2025-05-1677$7.28
$560.56Sell
Teresa L. YoungEVP Chief Commercial Strategy Officer2025-05-1663$7.28
$458.64Sell
Thomas DesrosierChief Legal Officer and EVP2025-05-1579$7.28
$575.12Sell
Matthew R. HennChief Scientific Officer and EVP2025-02-183,953$0.81
$3.20kSell
Teresa L. YoungEVP Chief Commercial Strategy Officer2025-02-183,338$0.81
$2.70kSell
Moltke Lisa VonExecutive Vice President and Chief Medical Officer2025-02-184,416$0.81
$3.58kSell
Thomas DesrosierChief Legal Officer and EVP2025-02-184,300$0.81
$3.48kSell
Eric D. ShaffCEO and President2025-02-1812,726$0.81
$10.31kSell
Eric D. ShaffCEO and President2024-11-182,505$0.54
$1.36kSell

1 of 3

MCRB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MCRB insiders and whales buy or sell their stock.

MCRB Shareholders

What type of owners hold Seres Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Nutritional Health Ltp Fund General Partner LLC273.34%23,869,081$179.02MInsider
Flagship Pioneering Inc264.73%23,117,045$173.38MInstitution
Fmr LLC250.67%21,889,432$164.17MInstitution
Sa Nestle250.56%21,879,753$164.10MInsider
Nestle Health Science Us Holdings Inc78.89%6,888,888$51.67MInsider
Vanguard Group Inc69.76%6,091,999$45.69MInstitution
Flagship Pioneering Fund VII General Partner LLC66.71%5,825,495$43.69MInsider
Flagship Pioneering Inc50.90%4,444,444$33.33MInsider
Noubar Afeyan31.49%2,750,135$20.63MInsider
Blackrock Inc20.18%1,762,157$13.22MInstitution

1 of 3

MCRB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MCRB47.82%52.18%Net SellingNet Selling
IMMX10.47%31.44%Net Buying
ANRO75.60%24.40%Net Buying
MNOV10.61%89.10%
IKNA67.86%18.22%
View Top Biotech Stocks

Seres Therapeutics Stock Ownership FAQ

Who owns Seres Therapeutics?

Seres Therapeutics (NASDAQ: MCRB) is owned by 704.39% institutional shareholders, 768.57% Seres Therapeutics insiders, and 0.00% retail investors. Nutritional Health Ltp Fund General Partner LLC is the largest individual Seres Therapeutics shareholder, owning 23.87M shares representing 273.34% of the company. Nutritional Health Ltp Fund General Partner LLC's Seres Therapeutics shares are currently valued at $179.02M.

If you're new to stock investing, here's how to buy Seres Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.